The store will not work correctly when cookies are disabled.
3-Methyl-thieno[2,3-b]pyrrolizin-8-one O-(2-piperidin-1-yl-ethyl)-oxime
ID: ALA342138
PubChem CID: 44360710
Max Phase: Preclinical
Molecular Formula: C17H21N3OS
Molecular Weight: 315.44
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1csc2c1-n1cccc1/C2=N/OCCN1CCCCC1
Standard InChI: InChI=1S/C17H21N3OS/c1-13-12-22-17-15(14-6-5-9-20(14)16(13)17)18-21-11-10-19-7-3-2-4-8-19/h5-6,9,12H,2-4,7-8,10-11H2,1H3/b18-15-
Standard InChI Key: MPZDFMTUBDIVPH-SDXDJHTJSA-N
Molfile:
RDKit 2D
22 25 0 0 0 0 0 0 0 0999 V2000
4.9167 -2.7875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9792 -1.4542 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.7167 -2.5667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4667 -2.0917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7542 -1.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4000 -3.4292 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
3.6667 -2.3042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6250 -3.1292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3542 -3.0875 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.0250 -0.6292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2750 -1.1042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0042 -4.3792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8167 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9417 -3.6667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.7667 -3.6667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1792 -4.3792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0292 -1.7875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4167 -5.0917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4125 -3.6667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2375 -3.6667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2375 -5.0917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6417 -4.3792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 4 1 0
3 1 1 0
4 1 2 0
5 3 1 0
6 1 1 0
7 4 1 0
8 6 1 0
9 3 2 0
10 2 1 0
11 5 2 0
12 16 1 0
13 10 2 0
14 9 1 0
15 14 1 0
16 15 1 0
17 7 1 0
18 12 1 0
19 12 1 0
20 19 1 0
21 18 1 0
22 20 1 0
8 7 2 0
5 2 1 0
13 11 1 0
22 21 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 315.44 | Molecular Weight (Monoisotopic): 315.1405 | AlogP: 3.42 | #Rotatable Bonds: 4 |
Polar Surface Area: 29.76 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 7.92 | CX LogP: 4.02 | CX LogD: 3.39 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.55 | Np Likeness Score: -1.27 |
References
1. Baglin I, Daveu C, Lancelot JC, Bureau R, Dauphin F, Pfeiffer B, Renard P, Delagrange P, Rault S.. (2001) First tricyclic oximino derivatives as 5-HT3 ligands., 11 (4): [PMID:11229746] [10.1016/s0960-894x(00)00691-0] |